IN8BIO, Inc.
INAB· Nasdaq
INABIN8BIO, Inc.
Filed Aug 12, 2022 · 10-Q · 43 days after period end · 0000950170-22-017132
| Metric | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|
| Net Income | -$7.18M | -$3.05M | -$2.87M |
| EPS Diluted | -$0.38 | -$1.00 | -$0.92 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IN8BIO, Inc. · CIK 1740279 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 12, 2022 · 43 d after period end
